Showing results (131-140 of 154) with videos related to
Sort By:
Pageof 16
Frontiers in Oncology|September 5, 2024
Estimated incidence of disruptions to event-free survival from non-metastatic cancers in New South Wales, Australia - a population-wide epidemiological study of linked cancer registry and treatment dataStephen Morrell, David Roder, David Currow, et al.Health Policy (Amsterdam, Netherlands)|January 6, 2021
A survey of Australian public attitudes towards funding of high cost cancer medicinesNarcyz Ghinea, Christine Critchley, Bronwen Morrell, et al.BMC Health Services Research|February 12, 2020
What are the attitudes of health professionals regarding patient reported outcome measures (PROMs) in oncology practice? A mixed-method synthesis of the qualitative evidenceBróna Nic Giolla Easpaig, Yvonne Tran, Mia Bierbaum, et al.BMJ Open|February 20, 2020
Risk of opioid misuse in people with cancer and pain and related clinical considerations: a qualitative study of the perspectives of Australian general practitionersTim Luckett, Toby Newton-John, Jane Phillips, et al.Biomarker Insights|February 17, 2022
Moving with the Times: The Health Science Alliance (HSA) Biobank, Pathway to SustainabilityCarmel M Quinn, Mamta Porwal, Nicola S Meagher, et al.The Oncologist|March 25, 2015
Migrant health in cancer: outcome disparities and the determinant role of migrant-specific variablesMing Sze, Phyllis Butow, Melanie Bell, et al.Patient Education and Counseling|April 2, 2013
Should culture affect practice? A comparison of prognostic discussions in consultations with immigrant versus native-born cancer patientsPhyllis N Butow, Ming Sze, Maurice Eisenbruch, et al.Pathology|June 25, 2019
Expression of cancer stem cell markers is prognostic in metastatic gastroesophageal adenocarcinomaDaniel Brungs, Alistair Lochhead, Anita Iyer, et al.BMJ Open|October 12, 2019
What is multidisciplinary cancer care like in practice? a protocol for a mixed-method study to characterise ambulatory oncology services in the Australian public sectorBróna Nic Giolla Easpaig, Gaston Arnolda, Yvonne Tran, et al.Cancer Chemotherapy and Pharmacology|March 23, 2021
Pharmacogenomics and functional imaging to predict irinotecan pharmacokinetics and pharmacodynamics: the predict IR studyMichael Michael, Winston Liauw, Sue-Anne McLachlan, et al.Pageof 16